Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 20, 2019

View Archived Issues

Exosome-derived miRNAs from colon cancer cells promote fibroblast proliferation and tumor growth

Bone-deep stress

CAR relative CCR may offer targeting advantages

Rare eye disease gives clues to peripheral neuropathy

Researchers unveil the role of vasorin in angiogenesis and tumor progression in glioma

CinDome Pharma initiates phase II study of deuterated domperidone

PDS Biotechnology presents phase I data for its novel immunotherapy PDS-0101

Positive topline results presented from phase III study of contezolid in cSSTI

NfL as biomarker for early diagnosis of polyneuropathy in patients with hATTR amyloidosis

Melflufen plus dexamethasone show encouraging activity in advanced RRMM with EMD

LUBAC identified as a biomarker of prognosis and potential therapeutic target in lung cancer

SASH1 as a predictive biomarker for sensitivity to PARP inhibitors

Phase Ib data on IMCY-0098 in young adults with recent-onset type 1 diabetes presented

U.S. investigators patent KRAS mutant inhibitors

Dart NeuroScience divulges new OPRL1 antagonists

Incyte presents new adenosine A2A and/or A2B receptor antagonists

Annapurna Bio discovers apelin receptor agonists

Caveolin-1 deficiency links type 2 diabetes to sporadic AD

Takeda Pharmaceutical identifies somatostatin SST4 receptor agonists

Xortx reports promising phase II data with TMX-049 in type 2 diabetic nephropathy

Japanese approval for Evrenzo for anemia associated with chronic kidney disease in dialysis patients

Y-Trap, Merck KGaA announce immuno-oncology collaboration

Lasvic approved in Japan to treat respiratory and ENT infections

A1M reports initial phase Ia data on ROSgard

Aslan reports phase II data from Chinese study of varlitinib in second-line biliary tract cancer

Grand Challenge grant supports University of Chicago-led development of universal influenza vaccine

Affibody collaborates with GE Healthcare to develop Affibody-based PET imaging tracers

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026